BGMA Chief Samuels Sees Boost From UK Biosimilars Pathway
Also Sets Out Aspirations For Repurposing Project And COVID Expectations
• By David Wallace
Mark Samuels sees the new MHRA biosimilars pathway as a “win-win” for developers and the NHS • Source: BGMA 
